Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
J0300146	羟萘酸沙美特罗	Salmeterol Hydroxynaphthoate	Active ingredient	Chemical Drugs	License Renew	2003-02-24		GlaxoSmithKline (China) Investment Co Ltd	Certificate Completed-Pending Issued	2003-07-28	view
JYHB0900901	羟萘酸沙美特罗吸入粉雾剂	Salmeterol Hydroxynaphthoate	Powder for inhalation	Chemical Drugs	Supplementary Application	2009-10-13	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome Production;Glaxo Wellcome Operations	Certificate Issued	2010-10-19	view
JYHZ1300226	羟萘酸沙美特罗	Salmeterol Hydroxynaphthoate	Active ingredient	Chemical Drugs	License Renew	2013-10-28	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome Operations	In Approval	2017-02-27	view
JYHB1401292	羟萘酸沙美特罗吸入粉雾剂	Salmeterol Hydroxynaphthoate	Powder for inhalation	Chemical Drugs	Supplementary Application	2014-09-22	Glaxo Wellcome UK Limited	Glaxo Wellcome Operations;Glaxo Wellcome Production	Certificate Issued	2015-10-30	view